Follwoing a a suspected bat bite Caroline Ford, worried she may have been exposed to rabies, sought treatment from AdventHealth Altamonte Springs. She called her insurance company, Anthem Blue Cross, and expected she'd need ...
Feb 20, 2024
0
1
A Colorado board voted unanimously Feb. 16 to consider setting a maximum price for a drug to treat autoimmune diseases, launching the state into uncharted territory and setting up a possible showdown with the drug's manufacturer.
Feb 19, 2024
0
0
Last year alone, David Mitchell paid $16,525 for 12 little bottles of Pomalyst, one of the pricey medications that treat his multiple myeloma, a blood cancer he was diagnosed with in 2010.
Feb 19, 2024
0
1
Only a small percentage of older Americans have jumped on the rising trend of getting health care services and prescriptions directly from an online-only company, rather than seeing their usual health care providers in person ...
Jan 15, 2024
0
0
Erinn Maury knew Remicade wasn't the right drug for Patti Schulte, a rheumatoid arthritis patient the physician saw at her Millersville, Maryland, practice. Schulte's swollen, painful joints hadn't responded to Enbrel or ...
Dec 28, 2023
0
28
A French appeals court on Wednesday ordered pharmaceutical firm Servier to pay more than $460 million in damages over a scandal involving a diabetes drug linked to hundreds of deaths.
Dec 20, 2023
0
0
Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical ...
Dec 14, 2023
0
0
A California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stress disorder (PTSD).
Dec 13, 2023
0
1
The use of prior authorizations by insurance companies for certain oral cancer drugs can lead to significant delays in patients' obtaining the medication and make it more likely that some would discontinue the drug, according ...
Dec 13, 2023
0
0
The Biden administration is flexing some federal muscle in its push for lower drug prices, warning pharmaceutical companies that it might use its authority to cancel patent protections if a medication costs too much.
Dec 7, 2023
0
10
